Impact du pharmacien clinicien sur la iatrogénie médicamenteuse chez le patient greffé rénal

Macedo, 2011, Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions, J Nurs Manag, 19, 395, 10.1111/j.1365-2834.2011.01216.x Abbott, 2002, Hospitalized poisonings after renal transplantation in the United States, BMC Nephrol, 3, 10, 10.1186/1471-2369-3-10 Morales, 2012, Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain, Clin Transplant, 26, 369, 10.1111/j.1399-0012.2011.01544.x Gordon, 2009, Medication-taking among adult renal transplant recipients: barriers and strategies, Transpl Int, 22, 534, 10.1111/j.1432-2277.2008.00827.x Marquet, 2007, Pharmacogenetics and immunosuppressor drugs: impact and clinical interest in transplantation, Ann Pharm Fr, 65, 382, 10.1016/S0003-4509(07)74197-4 Van Gelder, 2009, Mycophenolate blood level monitoring: recent progress, Am J Transplant, 9, 1495, 10.1111/j.1600-6143.2009.02678.x Glowacki, 2011, CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on tacrolimus dose requirements and clinical outcome after renal transplantation, Nephrol Dial Transplant, 26, 3046, 10.1093/ndt/gfr253 Kurzawski, 2005, The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients, Ther Drug Monit, 27, 435, 10.1097/01.ftd.0000164393.09402.c9 Relling, 2011, Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing, Clin Pharmacol Ther, 89, 387, 10.1038/clpt.2010.320 Blix, 2006, Use of renal risk drugs in hospitalized patients with impaired renal function--an underestimated problem?, Nephrol Dial Transplant, 21, 3164, 10.1093/ndt/gfl399 Taber, 2014, Clinical and economic outcomes associated with medication errors in kidney transplantation, Clin J Am Soc Nephrol, 9, 960, 10.2215/CJN.09300913 Bond, 1999, Clinical pharmacy services and hospital mortality rates, Pharmacotherapy, 19, 556, 10.1592/phco.19.8.556.31531 SFPC Mémo Conciliation des traitements médicamenteux 2017. http://sfpc.eu/fr/item1/finish/34-documents-sfpc-public/1608-sfpc-memo-conciliation-v2016/0.html. Pérennes, 2012, Medication reconciliation: an innovative experience in an internal medicine unit to decrease errors due to inacurrate medication histories, Presse Med, 41 Murphy, 2009, Medication reconciliation at an academic medical center: implementation of a comprehensive program from admission to discharge, Am J Health Syst Pharm, 66, 2126, 10.2146/ajhp080552 Cornu, 2012, Effect of medication reconciliation at hospital admission on medication discrepancies during hospitalization and at discharge for geriatric patients, Ann Pharmacother, 46, 484, 10.1345/aph.1Q594 Leguelinel-Blache, 2015, Improving patient's primary medication adherence: the value of pharmaceutical counseling, Medicine (Baltimore), 94, e1805, 10.1097/MD.0000000000001805 Haute Autorité de santé (HAS), 2016 Koehler, 2009, Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle, J Hosp Med, 4, 211, 10.1002/jhm.427 Hellström, 2011, Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits, Eur J Clin Pharmacol, 67, 741, 10.1007/s00228-010-0982-3 Chisholm, 2006, A renal transplantation advanced pharmacy practice experience, Am J Pharm Educ, 70, 3, 10.5688/aj700103 Chisholm-Burns, 2008, Impact of clinical pharmacy services on renal transplant recipients’ adherence and outcomes, Patient Pref Adher, 2, 287, 10.2147/PPA.S4174 Leguelinel-Blache, 2014, Impact of admission medication reconciliation performed by clinical pharmacists on medication safety, Eur J Intern Med, 25, 808, 10.1016/j.ejim.2014.09.012 Doerper, 2013, La conciliation des traitements médicamenteux : logigramme d’une démarche efficiente pour prévenir ou intercepter les erreurs médicamenteuses à l’admission du patient hospitalisé, Pharm Hosp Clin, 48, 153 Queneau, 2005, Adverse drug effects: a prospective study by Apnet performed in seven emergency care units in France: propositions for preventive measures, Ann Pharm Fr, 63, 131, 10.1016/S0003-4509(05)82263-1 Girerd, 2001, Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic, Press Med, 30, 1044 Morisky, 2008, Predictive validity of a medication adherence measure in an outpatient setting, J Clin Hypertens (Greenwich), 10, 348, 10.1111/j.1751-7176.2008.07572.x Musgrave, 2013, Improving transplant patient safety through pharmacist discharge medication reconciliation, Am J Transplant, 13, 796, 10.1111/ajt.12070 Agence de la biomédecine 2005, Direction de la recherche, des études, de l’évaluation et des statistiques (Drees). Les événements indésirables graves liés aux soins observés dans les établissements de santé : premiers résultats d’une étude nationale, Etud Res, 398, 1 Pouyanne, 2000, Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres, BMJ, 320, 1036, 10.1136/bmj.320.7241.1036 Queneau, 2007, Emergency department visits caused by adverse drug events: results of a French survey, Drug Saf, 30, 81, 10.2165/00002018-200730010-00008 Hansen, 2007, Medication adherence in chronic disease: issues in posttransplant immunosuppression, Transplant Proc, 39, 1287, 10.1016/j.transproceed.2007.02.074 Chisholm-Burns, 2012, Factors related to immunosuppressant medication adherence in renal transplant recipients, Clin Transplant, 26, 706, 10.1111/j.1399-0012.2011.01589.x Couzi, 2013, Factors predictive of medication nonadherence after renal transplantation: a French observational study, Transplantation, 95, 326, 10.1097/TP.0b013e318271d7c1 Taber, 2013, Improved patient safety and outcomes with a comprehensive interdisciplinary improvement initiative in kidney transplant recipients, Am J Med Qual, 28, 103, 10.1177/1062860612450309 Chisholm, 2001, Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications, Clin Transplant, 15, 330, 10.1034/j.1399-0012.2001.150505.x Doucet, 2012, Preventable and non-preventable risk factors for adverse drug events related to hospital admissions in the elderly, Clin Drug Invest, 22, 385, 10.2165/00044011-200222060-00006 Warholak, 2009, An exploratory comparison of medication lists at hospital admission with administrative database records, J Manag Care Pharm, 15, 751, 10.18553/jmcp.2009.15.9.751 Coordination CRPV de Bordeaux, 2007 Perault, 1999, Prospective study on admissions for iatrogenic adverse effects in the emergency service of hospital university center in Poitiers, Therapie, 54, 183 Almanasreh, 2016, The medication reconciliation process and classification of discrepancies: a systematic review, Br J Clin Pharmacol, 82, 645, 10.1111/bcp.13017 Lee, 2010, Medication reconciliation during internal hospital transfer and impact of computerized prescriber order entry, Ann Pharmacother, 44, 1887, 10.1345/aph.1P314 Beers, 1990, The accuracy of medication histories in the hospital medical records of elderly persons, J Am Geriatr Soc, 38, 1183, 10.1111/j.1532-5415.1990.tb01496.x Gleason, 2010, Results of the Medications at Transitions and Clinical Handoffs (MATCH) study: an analysis of medication reconciliation errors and risk factors at hospital admission, J Gen Intern Med, 25, 441, 10.1007/s11606-010-1256-6 Belaiche, 2012, Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study, J Nephrol, 25, 782, 10.5301/jn.5000063